Search
Zai Lab Ltd
ZLABAdd to Watchlist
24.600USD
-1.440-5.53%
Close 11-13 16:00（ET）
2.76BMarket Cap
LossP/E TTM
Zai Lab Ltd (ZLAB) Stock Price Target & Forecast
Analyst Rating
Based on 11 analysts giving stock ratings to Zai Lab Ltd in the past month.
Buy
3 Strong Buy
7 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
32.880USD+48.98%
ZLAB Analyst Recommendation Trends
In the current month, ZLAB has received 7 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. ZLAB average Analyst price target in the last month is 32.880.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
3
3
3
3
3
3
3
3
7
7
8
8
8
8
8
8
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11
11
12
12
12
12
12
12
ZLAB Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
8
16
12
1
0
37
Amgen Inc
AMGN
4
9
19
3
1
36
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Eli Lilly and Co
LLY
10
19
3
1
0
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
AbbVie Inc
ABBV
8
18
6
0
0
32
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Merck & Co Inc
MRK
7
16
8
0
0
31
Gilead Sciences Inc
GILD
7
18
5
0
0
30
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
Financial Forecasting
Based on analysts' estimates, ZLAB EPS is projected to reach -0.568 in FY2026Q4, following reported EPS of -0.411 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.50
-0.62
-0.58
-0.57
-0.59
Actual
-0.46
-0.45
-0.41
--
--
Surprise
+8.48%
+26.33%
+28.85%
--
--
FAQs
What is Zai Lab Ltd's expected revenue for the next quarter?
Zai Lab Ltd's expected revenue is 109.78M.
What is Zai Lab Ltd's price target?
Analysts forecast that Zai Lab Ltd's price target is USD 32.88, with the highest forecast at USD 50.00 and the lowest forecast at USD 24.25.
How have Zai Lab LtdZLAB's recent earnings per share performed?
The market expectation was USD -0.41, while Zai Lab LtdZLAB's earnings per share (EPS) for the previous quarter was USD -0.45. EPS for the next quarter is expected at USD -0.57.
What is the analyst rating for Zai Lab Ltd?
Based on the ratings of Zai Lab Ltd's stock from 11 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.